A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₩132,974.14, with a 24-hour trading volume of ₩1.21T. The asset's market cap is ₩412.29T, after moving 0.16% in the last day.
Tokenized AstraZeneca PLC is trading at ₩134,754.44, with a tokenized market cap of ₩1.01B and a 24-hour trading volume of ₩975.36M. The tokenized asset has moved 1.45% in the past 24 hours.